Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 43

    1.

    Addition of rituximab to high-dose methotrexate-based chemotherapy improves survival of adults with Burkitt lymphoma/leukemia.

    Dujmovic D, Aurer I, Radman I, Serventi-Seiwerth R, Dotlic S, Stern-Padovan R, Dubravcic K, Santek F, Labar B.

    Acta Haematol. 2012;127(2):115-7. Epub 2011 Dec 31. No abstract available.

    PMID:
    22212303
    [PubMed - indexed for MEDLINE]
    2.

    The PML gene of the PML-RARα V-form fusion transcript breaks within exon 6.

    Qi X, Tan Y, Chen X, Bian S, Zhang L, Xu A, Xu Z, Wang H.

    Acta Haematol. 2011;126(4):216-9. Epub 2011 Sep 20. No abstract available.

    PMID:
    21934296
    [PubMed - indexed for MEDLINE]
    3.

    Acute lymphoblastic leukaemia with an e1a3 BCR-ABL1 fusion.

    Langabeer SE, Haslam K, Kelly J, Leahy M, Vandenberghe E.

    Acta Haematol. 2011;126(4):214-5. Epub 2011 Sep 16. No abstract available.

    PMID:
    21934295
    [PubMed - indexed for MEDLINE]
    4.

    Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.

    Saini L, Minden MD, Schuh AC, Yee KW, Schimmer AD, Gupta V, Atenafu EG, Murray C, Nixon S, Brandwein JM.

    Am J Hematol. 2012 Mar;87(3):323-6. doi: 10.1002/ajh.22268. Epub 2011 Dec 27.

    PMID:
    22213349
    [PubMed - indexed for MEDLINE]
    5.

    Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm.

    Rumi E, Harutyunyan A, Elena C, Pietra D, Klampfl T, Bagienski K, Berg T, Casetti I, Pascutto C, Passamonti F, Kralovics R, Cazzola M.

    Am J Hematol. 2011 Dec;86(12):974-9. doi: 10.1002/ajh.22166. Epub 2011 Sep 22.

    PMID:
    21953568
    [PubMed - indexed for MEDLINE]
    6.

    Utility of 18F-FDG PET/CT in identifying terminal ileal myeloid sarcoma in an asymptomatic patient.

    Lee EY, Leung AY, Anthony MP, Loong F, Khong PL.

    Am J Hematol. 2011 Dec;86(12):1036-7. doi: 10.1002/ajh.22077. Epub 2011 Jul 28. No abstract available.

    PMID:
    21800353
    [PubMed - indexed for MEDLINE]
    7.

    Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia.

    Iori AP, Valle V, Piciocchi A, Meloni G, Torelli GF, Vitale A, Testi AM, Barberi W, Ricci R, Milano F, Lucarelli B, Screnci M, Perrone MP, Laurenti L, Natalino F, Perrone S, Sacchi N, Arcese W, Foà R.

    Ann Hematol. 2012 Jun;91(6):941-8. Epub 2012 Jan 3.

    PMID:
    22209945
    [PubMed - in process]
    8.

    Apatinib (YN968D1) enhances the efficacy of conventional chemotherapeutical drugs in side population cells and ABCB1-overexpressing leukemia cells.

    Tong XZ, Wang F, Liang S, Zhang X, He JH, Chen XG, Liang YJ, Mi YJ, To KK, Fu LW.

    Biochem Pharmacol. 2012 Mar 1;83(5):586-97. Epub 2011 Dec 16.

    PMID:
    22212563
    [PubMed - indexed for MEDLINE]
    9.

    Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

    Kang H, Wilson CS, Harvey RC, Chen IM, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Stam RW, Valsecchi MG, Pieters R, Heerema NA, Hilden JM, Felix CA, Reaman GH, Camitta B, Winick N, Carroll WL, Dreyer ZE, Hunger SP, Willman CL.

    Blood. 2012 Feb 23;119(8):1872-81. Epub 2011 Dec 30.

    PMID:
    22210879
    [PubMed - indexed for MEDLINE]
    10.

    Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.

    Xi L, Arons E, Navarro W, Calvo KR, Stetler-Stevenson M, Raffeld M, Kreitman RJ.

    Blood. 2012 Apr 5;119(14):3330-2. Epub 2011 Dec 30.

    PMID:
    22210875
    [PubMed - in process]
    11.

    Anti-CD20: tales of identical twins?

    Schuh A.

    Blood. 2011 Nov 10;118(19):5066-7. No abstract available.

    PMID:
    22077072
    [PubMed - indexed for MEDLINE]
    12.

    Sleeping beauty: does ETP-ALL awaken later?

    Dose M, Gounari F.

    Blood. 2011 Oct 27;118(17):4500-1. No abstract available.

    PMID:
    22033941
    [PubMed - indexed for MEDLINE]
    13.

    CML: live long and prosper.

    Larson RA.

    Blood. 2011 Oct 27;118(17):4499-500. No abstract available.

    PMID:
    22033940
    [PubMed - indexed for MEDLINE]
    14.

    CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101.

    Jak M, van Bochove GG, Reits EA, Kallemeijn WW, Tromp JM, Umana P, Klein C, van Lier RA, van Oers MH, Eldering E.

    Blood. 2011 Nov 10;118(19):5178-88. Epub 2011 Sep 26.

    PMID:
    21948297
    [PubMed - indexed for MEDLINE]
    15.

    C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.

    Bisaillon R, Wilhelm BT, Krosl J, Sauvageau G.

    Blood. 2011 Oct 27;118(17):4682-9. Epub 2011 Sep 7.

    PMID:
    21900201
    [PubMed - indexed for MEDLINE]
    16.

    Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.

    Ho PA, Kopecky KJ, Alonzo TA, Gerbing RB, Miller KL, Kuhn J, Zeng R, Ries RE, Raimondi SC, Hirsch BA, Oehler V, Hurwitz CA, Franklin JL, Gamis AS, Petersdorf SH, Anderson JE, Godwin JE, Reaman GH, Willman CL, Bernstein ID, Radich JP, Appelbaum FR, Stirewalt DL, Meshinchi S.

    Blood. 2011 Oct 27;118(17):4561-6. Epub 2011 Aug 26.

    PMID:
    21873548
    [PubMed - indexed for MEDLINE]
    17.

    Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation.

    Kohrt HE, Müller A, Baker J, Goldstein MJ, Newell E, Dutt S, Czerwinski D, Lowsky R, Strober S.

    Blood. 2011 Nov 10;118(19):5319-29. Epub 2011 Aug 25.

    PMID:
    21868578
    [PubMed - indexed for MEDLINE]
    18.

    Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.

    Cortes JE, Kantarjian HM, Brümmendorf TH, Kim DW, Turkina AG, Shen ZX, Pasquini R, Khoury HJ, Arkin S, Volkert A, Besson N, Abbas R, Wang J, Leip E, Gambacorti-Passerini C.

    Blood. 2011 Oct 27;118(17):4567-76. Epub 2011 Aug 24.

    PMID:
    21865346
    [PubMed - indexed for MEDLINE]
    19.

    Ofatumumab is active in patients with fludarabine-refractory CLL irrespective of prior rituximab: results from the phase 2 international study.

    Wierda WG, Padmanabhan S, Chan GW, Gupta IV, Lisby S, Osterborg A; Hx-CD20-406 Study Investigators.

    Blood. 2011 Nov 10;118(19):5126-9. Epub 2011 Aug 19.

    PMID:
    21856867
    [PubMed - indexed for MEDLINE]
    20.

    Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

    Ben Abdelali R, Asnafi V, Leguay T, Boissel N, Buzyn A, Chevallier P, Thomas X, Lepretre S, Huguet F, Vey N, Escoffre-Barbe M, Tavernier E, Reman O, Fegueux N, Turlure P, Rousselot P, Cahn JY, Lheritier V, Chalandon Y, Béné MC, Macintyre E, Dombret H, Ifrah N; Group for Research on Adult Acute Lymphoblastic Leukemia.

    Blood. 2011 Nov 10;118(19):5099-107. Epub 2011 Aug 11.

    PMID:
    21835957
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk